Searchable abstracts of presentations at key conferences in endocrinology

ea0021p122 | Cytokines and growth factors | SFEBES2009

Impact of adiposity on dynamic changes of serum adipokines after OGTT

Banerjee Moulinath , Pemberton Phillip , Charlton-Menys Valentyn , Fraser William , Cruickshank Kennedy

Introduction: Data are conflicting on whether and how serum adipokines alter following acute dietary intake. Here, we used the specific challenge of standard 75 g glucose tolerance tests (GTT) to assess timed changes in TNF-α, IL-6, leptin and adiponectin in healthy younger women and how these would be affected by adiposity.Methods: Consenting participants in the Manchester Mothers’ Heart and Vascular health study had serum adipokines measured ...

ea0015p18 | Bone | SFEBES2008

Expression and function of gut hormone receptors in osteoblast cell lines

Pacheco-Pantoja Elda , Wilson Peter , Ranganath Lakshminarayan , James Gallagher , Fraser William

The gastro-entero-pancreatic hormones are involved in the regulation of postprandial nutrient homeostasis. Food intake or fasting triggers the release of these hormones. A direct connection between food intake and bone turnover, assessed by biochemical markers of bone resorption and formation, has been demonstrated in animals and humans.The aim was to study the expression of receptors for the gut hormones, glucose-dependent insulinotropic polypeptide (GI...

ea0013oc19 | Novartis Basic Endocrinology Award | SFEBES2007

Steroidogenic gene transcription in the human hippocampus and cerebellum: a comprehensive survey

MacKenzie Scott , Dewar Deborah , Stewart William , Fraser Robert , Connell John , Davies Eleanor

Previous studies investigating steroidogenic enzymes in the brain have often focused on only a few genes at a time, using animal models or pooled human RNA to investigate their expression. For this study, we obtained RNA from individual archived human brain tissue samples in order to analyse the transcription of twelve genes involved with steroid biosynthesis and metabolism within the cerebellum and hippocampus.We developed realtime RT-PCR assays for twe...

ea0094op6.2 | Bone and Calcium | SFEBES2023

Measuring FGF23 in patients treated with burosumab

Piec Isabelle , Chipchase Allison , Miler Emma , Ramachandran Hari , Webb Emma , Fraser William D

Burosumab has become available as a treatment for children with X-linked hypophosphatemia (XLH) and is a recombinant fully human IgG1 against FGF23. By binding to the active FGF23, burosumab inhibits its effect and symptoms (growth retardation, rickets, enthesiopathy, low phosphate) may improve, however, not in all children. Concomitantly paediatricians are keen to measure FGF23, in treated children, to avoid overtreatment with burosumab, associated with potential calcificatio...

ea0095p10 | Bone | BSPED2023

LC–MS/MS measurements of serum zoledronate in children and young people receiving treatment – findings from the Moving Towards Individualised BisphosphonatE Therapy (TIBET) study

Bartlett Tabitha , Tang Jonathan C Y , Dunn Rachel , Subramanian Sharan , Fraser William D , Webb Emma

Background: Zoledronate is a nitrogen-containing bisphosphonate (BP) recognised for its antiresorptive potency. The pharmacokinetic/pharmacodynamic of zoledronate remains unclear. Although adverse events from overuse of BP is rare, there have been reports of over-treatment resulting in pathophysiological consequences. The current administration regimen is not tailored to the individual’s therapeutic response to zoledronate. Quantifying post-dose serum con...

ea0095p11 | Bone | BSPED2023

Assessment of children’s bone health: Establishing paediatric reference (prefer study) values for 1,25 vitamin D

Farag Amrou , Tang Jonathan C Y , Dunn Rachel , Chipchase Allison , Fraser William D , Webb Emma

Background: The active form of vitamin D, 1,25(OH)2D, plays a key role in regulating calcium and phosphorus metabolism and bone homeostasis. In paediatrics, maintaining optimal 1,25(OH)2D levels is crucial for supporting musculoskeletal growth. The hormone also serves as a diagnostic indicator for multiple disorders such as vitamin-D dependent rickets. Current Literature lacks comprehensive reporting of age-specific reference ranges in pa...

ea0044p72 | Clinical biochemistry | SFEBES2016

Changes in serum 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in response to three vitamin D3 supplementation regimens

Tang Jonathan , Nicholls Holly , Dutton John , Piec Isabelle , Washbourne Christopher , Saleh Lanja , Novak A , Close Graeme , Macdonald Helen , Fraser William

Background: 25-hydroxyvitamin D (25(OH)D) is metabolised into two forms of metabolites: 1,25-dihydroxyvitamin D (1,25(OH)2D) by the actions of 1α hydroxylase, and 24,25-dihydroxyvitamin D (24,25(OH)2D) by 24-hydroxylase. Studies suggest the production of 1,25(OH)2D is 24,25(OH)2D dependent. Genetic mutations of CYP24A1 gene resulting in reduced or total loss of 24-hydroxylase function are associated with hypercalcaemic condition...

ea0059oc1.2 | Translational highlights | SFEBES2018

Vitamin D insufficiency and elevated vitamin D metabolite ratios (VMR) are associated with increased risk of injuries: Results from the british army lower limb injury prevention (ALLIP) study

Tang Jonathan , Jackson Sarah , Izard Rachel , Oliver Samuel , Piec Isabelle , Washbourne Christopher , Walsh Neil , Greeves Julie , Fraser William

Introduction: British Army recruits suffer from musculoskeletal injuries (MSI) during initial training. Up to 10% suffer skeletal stress fracture (SFx) resulting in lost training days and medical attrition. There is evidence to suggest that vitamin D deficiency is prevalent in the army. Our aim was to determine vitamin D metabolites (VDM) in recruits upon starting training, and health outcomes after a 14-week training programme.Methods: ...